Group items matching

in title, tags, annotations or url

A Nottingham-based pharmacist has been struck off the General Pharmaceutical Council (GPhC) register for bringing "the profession into to disrepute" by stealing hundreds of thousands of pounds in a bid to settle his gambling debt. Peter Sameh Saad (33) spun a web of lies and duped a friend out of more than half a million pounds to fund his addiction and pretended he had "serious if not terminal" testicular cancer. "It is difficult to imagine a more heinous fraud than one predicated on feigning a cancer diagnosis", a GPC panel ruled. Saad committed three frauds on a total of £536,689.95 between September 2018 and May 2019. First, he tricked a friend, whom he knew through his local church, into sending him around £288,200 by claiming that his newly-purchased pharmacy in US was "seized" by the authorities over visa issues and that he "had some difficulty making the mortgage payments". Later Saad conned the same friend, named only as 'Person A' in court documents, into sending him a total of £127,150 by lying about a non-existent cancer diagnosis and private treatment. Finally, he extracted a further £121,339.95 from an investments and credit group (named Company A) of which his friend was chief executive after inviting him to set up a 'pharmaceutical warehouse', a plan that "impressed Person A and he agreed to invest in the business."

Drugmakers GSK, Pfizer, Sanofi and Boehringer Ingelheim on Tuesday were spared thousands of US lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science. The ruling by US District Judge Robin Rosenberg in West Palm Beach, Florida, knocks out about 50,000 claims in federal court, though it does not directly affect tens of thousands of similar cases pending in state courts around the country. "We are extremely surprised by this miscarriage of justice," and "fully expect" the ruling will be reversed on appeal, lawyers for the plaintiffs said in a joint statement. A Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50 per cent," with the remaining litigation being only in state court. A spokesperson for GSK said the company welcomed the decision and Pfizer said it was pleased by the outcome. Privately-held German drugmaker Boehringer said in a statement that it looked forward to "continuing our vigorous defense of the remaining cases in state courts."

Amgen Inc sued Novartis AG's Sandoz in a federal court in the United States on Monday (May 1), accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents. Amgen asked the New Jersey court to block Sandoz's biosimilars of the drugs until its patents expire. One of the patents named in the complaint does not expire until 2037. Sandoz declined to comment on the lawsuit on Tuesday. Novartis, which is also named in the complaint, is preparing to spin Sandoz off into a standalone company later this year. Amgen's Prolia is used to treat osteoporosis. Xgeva, with the same active ingredient denosumab, treats bone cancer and prevents fractures in bone-cancer patients.

The National Health Service England (NHSE) aims to eliminate cervical cancer by 2040 by making the lifesaving Human Papillomavirus (HPV) vaccination easily accessible to people and increasing cervical screening uptake. In addition to the campaign, the NHS is expanding the outreach of cervical screening more than ever before. Last year, the health service invited over five million people aged 25 to 64 for the screening, out of which 3.5 million were tested. Moreover, self-sampling will be trialled to see if the service can introduced as part of national screening. England is among the first countries in the world to set this elimination ambition, which could save thousands of lives every year in the country. Amanda Pritchard, chief executive of Officer of NHS England, announced the health service's new goal and how to achieve it at the NHS Providers' annual conference today (15 November).

The Health and Social Care Secretary has announced over £175 million funding to boost genomics research in the UK. Through this funding, the government aims to create the most advanced genomic healthcare system in the world. "Patients with cancer and children born with treatable rare genetic diseases are set to benefit from earlier diagnosis and faster access to treatment, following a £175 million boost to cutting-edge genomics research announced by the Health and Social Care Secretary today (Tuesday)," said DHSC. The funding will enable research which could deliver world-leading genomic healthcare to patients, which involves the study of people's DNA. "£105 million to be funded to kickstart a world-leading research study, led by Genomics England in partnership with the NHS, to explore the effectiveness of using whole genome sequencing to find and treat rare genetic diseases in newborn babies," said DHSC. "An initial £26 million to support an innovative cancer programme, led by Genomics England in partnership with the NHS, to evaluate cutting-edge genomic sequencing technology to improve the accuracy and speed of diagnosis for cancer patients and use artificial intelligence to analyse a person's DNA, alongside other information such as routine scans.

"Anything is possible with focused strength, resilience and determination" said Bhavin Shah, Financial Director at Sigma Pharmaceuticals plc, after completing the annual London Marathon. Shah donned his running gear and completed the 26.2 mile route in a commendable time of 5 hours and 33 minutes, all in support of 'Team George', a cause initiated by his close friend, Jonathan Bracey, who is the EVP of corporate development at Tanner Pharma Group. Bracey started the crowdfunding initiative last year after his 2-year-old son George was diagnosed with a rare cancer (rhabdomyosarcoma) on his liver/bile duct. Sigma Pharmaceuticals directors and staff have played a vital part in helping raise over £52,000 over the last 6 months for 'Team George', which included the London Marathon Charity run on Sunday 21 April 2024. The funds will be donated to four charities that have been instrumental in George's path to overcoming cancer - Rays of Sunshine ward at Kings College Hospital Charity, St Mary's Hospital, Alice's Arc and Great Ormond Street Hospital. For over three months, Shah had been training himself physically and mentally for the marathon run to support his friend's initiative. He joined Bracey in the marathon, along with more than 50,000 other competitors.

Regular health screenings are an essential part of maintaining wellness, and one vital test for women is the Pap smear. Known for its role in early detection of cervical cancer, the Pap smear is a simple yet powerful tool that can potentially save lives. In this blog, we will explore the significance of Pap smears, what the procedure involves, and how often you should get tested. The Importance of Regular Local Screenings Staying on top of your health requires vigilance, and regular local screenings play an indispensable role in this effort. Local screenings, like Pap smears, are essential in detecting potential health issues at their earliest stages, making treatments more effective and improving outcomes. By participating in these routine checks, you not only safeguard your health but also contribute to broader public health efforts by identifying and addressing potential outbreaks or health trends within the community. Whether that's HPV and Pap tests in Singapore or a mammogram in the US, local screenings are crucial for maintaining overall wellness. This is especially true for Pap smears, as they play a significant role in detecting and preventing cervical cancer.

Did you know that pancreatic cancer has the least survival rates of all cancers? check out everything you need to know about the disease

A University of Queensland research, which offers potential new strategies and targets possibility in cancers has revealed how fats including cholesterol speedfies the progression of aggressive cancers in a human being. The study has been published in the Journal of Proteome Research.

One of the most common gynecologic diseases is Ovarian Cancer or Epithelial carcinoma of the ovary. This disease is serious. It has a very high mortality rate. This disease is the fifth most frequent cause of cancer death in women. Ovarian cancer is most common in women above fifty years of age.

mammography and breast cancer risk

Symptoms usually don't appear until abnormal cervical cells become cancerous and invade nearby tissue.

Thyroid cancer symptoms - Discover about thyroid cancer symptoms, thyroid cancer prognosis, thyroid cancer treatment and thyroid problem symptoms

Advancement towards the exploration associated with prostate cancer continues to be slow due to lack of suited animal model that will properly reproduce the spectrum of benign, latent, aggressive and metastatic sorts of the human diseases, helping researching the spectrum of this human disease.http://bit.ly/18hMhMU

Apollo Hospitals offer world class cancer treatment for medical & surgical oncology, skilfully performed by our highly trained oncologists who deliver best outcomes.

Know the Signs of Metastatic Breast Cancer and some of the best ways to support it . Customized pink wristbands are best way to support the cause.

Show your support and raise Lung Cancer Awareness with customized silicone wristbands and raise awareness.